NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression
(NASDAQ: ELAB) Delayed: 4.42 -0.36 (7.53%)
Previous Close $4.78    52 Week High $ 
Open $4.68    52 Week Low $ 
Day High $4.74    P/E N/A 
Day Low $4.35    EPS $ 
Volume 21,904